GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biosergen BIOSGN.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

—

FY2019FY2025

Net income

−SEK 40.8m

FY2019FY2025

Free cash flow

−SEK 36.8m

FY2019FY2025

Shareholders' equity

SEK 11.8m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue————SEK 8.6mSEK 4.4mSEK 1.3m
Research and development—————SEK 11.0mSEK 3.7m
Operating income−SEK 41.4m−SEK 20.7m−SEK 27.3m−SEK 34.1m−SEK 34.1m−SEK 6.2m−SEK 5.2m
Net income−SEK 40.8m−SEK 19.2m−SEK 27.0m−SEK 34.0m−SEK 34.6m−SEK 7.2m−SEK 5.4m
Diluted earnings per share-1.90-1.28-3.92-6.76-7.08-3.08-2.31

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsSEK 19.8mSEK 52.9mSEK 7.2mSEK 33.8mSEK 29.5mSEK 4.8mSEK 6.7m
Cash and short-term investmentsSEK 15.4mSEK 50.6mSEK 1.9mSEK 29.3mSEK 21.7mSEK 589,000SEK 5.2m
Total liabilitiesSEK 8.1mSEK 3.7mSEK 5.1mSEK 11.0mSEK 9.3mSEK 15.7mSEK 11.4m
Debt——————SEK 6.6m
Shareholders' equitySEK 11.8mSEK 48.2mSEK 2.1mSEK 22.8mSEK 20.2m−SEK 10.9m−SEK 4.7m
Shares outstanding21m15m7m5m5m2m2m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−SEK 36.8m−SEK 16.6m−SEK 32.6m−SEK 29.4m−SEK 37.7m−SEK 4.6m−SEK 2.3m
Free cash flow−SEK 36.8m−SEK 16.6m−SEK 32.6m−SEK 29.4m−SEK 37.7m−SEK 4.6m−SEK 2.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−SEK 5.2m−SEK 5.2m−SEK 12.5m−SEK 12.7m−SEK 11.0m−SEK 5.1m−SEK 4.7m−SEK 4.4m
Net income−SEK 5.2m−SEK 5.2m−SEK 12.5m−SEK 12.2m−SEK 11.0m−SEK 5.1m−SEK 3.7m−SEK 4.3m
Diluted earnings per share-2.23-2.23-0.58-0.57-0.51-0.24-0.25-0.29
Cash from operations−SEK 5.0m−SEK 5.0m−SEK 9.0m−SEK 10.0m−SEK 11.0m——−SEK 1.0m
Total assetsSEK 10.2mSEK 10.2mSEK 19.8mSEK 25.5mSEK 37.9mSEK 47.3mSEK 52.9mSEK 14.6m
Cash and short-term investmentsSEK 3.2mSEK 3.2mSEK 15.4mSEK 22.7mSEK 33.3mSEK 44.8mSEK 50.6mSEK 10.2m
Shareholders' equitySEK 704,000SEK 704,000SEK 11.8mSEK 20.3mSEK 32.6mSEK 43.4mSEK 48.2mSEK 11.7m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income6.6%46.1%—
Net income6.2%41.4%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-1.9-3.8-1.2-0.8-3.7
Price to sales————15.0

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 100-to-1 reverse split · 1 Dec 2025

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.